[使用FLT3抑制剂治疗AML的现状和挑战]
1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine.
概括
FLT3 抑制剂为患有 FLT3 突变的急性髓性白血病 (AML) 患者提供了新的希望. 目前正在进行研究,以克服耐药机制并优化组合疗法,以获得更好的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
